Sildenafil Tablet
Product Images NDC 68071-2602

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil (NDC 68071-2602). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 2602 3)

Sildenafil 20mg oral tablets label from NuCare Pharmaceuticals, Inc. The label indicates a package containing 30 tablets. It describes the tablets as circular white with debossing 'SC' on one side and '20' on the other. The label lists the manufacturer as Ajanta Pharma Limited. It includes storage instructions, warnings, and product identification details including the NDC 68071-2602-3.*

FDA Label Image

Figure1 (Sildenafil Figure 1)

A Kaplan-Meier type chart displaying estimated cumulative mortality rates over 5 years, separated by three dosage groups labeled High Dose, Medium Dose, and Low Dose. The x-axis represents time in years, and the y-axis shows the mortality rate percentage. A table above the chart indicates the number of subjects at risk at different time points for each dose group.*

FDA Label Image

Sildenafil_fig2 (Sildenafil Figure 2)

A chart showing the effects of various interacting drugs on the pharmacokinetics of Sildenafil tablets oral 20 mg. The graph compares fold changes with 90% confidence intervals in AUC and Cmax relative to Sildenafil alone for drugs like Atorvastatin, Azithromycin, Bosentan, and others, with corresponding dosage adjustment recommendations.*

FDA Label Image

Figure3 (Sildenafil Figure 3)

A chart titled "Interacting Drug" showing fold change and 90% confidence intervals for various drugs when coadministered with another drug. It lists drugs such as Acenocoumarol, Aspirin, Atorvastatin, Bosentan, and others, with corresponding fold change values on a horizontal axis from 0.5 to 2. Recommendations including "No dose adjustment" or "Coadministration not recommended" are provided for each drug based on the interaction data.*

FDA Label Image

Figure4 (Sildenafil Figure 4)

A line graph comparing change from baseline in meters over 12 weeks of study for different treatments: Placebo, Sildenafil 20 mg TID, and Sildenafil 80 mg TID. Data points with error bars are shown at weeks 4, 8, and 12, illustrating trends for each group over time.*

FDA Label Image

Figure5 (Sildenafil Figure 5)

A forest plot illustrating placebo-corrected changes in 6-minute walk distance (meters) for Sildenafil 20 mg taken three times daily (TID) across various subgroups. The plot compares subgroups based on baseline walk distance, etiology, functional class, gender, age, mean pulmonary arterial pressure (PAP), and pulmonary vascular resistance index (PVRI). Each subgroup is represented with point estimates and confidence intervals indicating the effect size of Sildenafil versus placebo.*

FDA Label Image

Figure6 (Sildenafil Figure 6)

A line graph showing the percentage of subjects without clinically worsening over a period of days from randomization. Two lines represent placebo and Sildenafil groups, with the Sildenafil group maintaining a higher percentage throughout the 112-day period.*

FDA Label Image

Sildenafil-figure-7 (Sildenafil Figure 7)

A line graph showing the mean change in meters from baseline over 12 weeks of study for Sildenafil tablets at 1 mg, 5 mg, and 20 mg doses taken three times daily (TID). The y-axis represents change from baseline in meters, and the x-axis shows weeks 4, 8, and 12. Data points include error bars indicating the standard error for each dose at each visit.*

FDA Label Image

Structure (Sildenafil Structure)

Chemical structure of Sildenafil, the active ingredient shown in the image, depicting its molecular configuration with labeled functional groups and ring systems.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.